AKT1 and ovarian cancer: The somatic mutation of AKT1 isoform associated with the substitution of glutamic acid by a lysine at amino acid 17 (E17K) of AKT1 has been reported in human breast, colorectal, ovarian cancers, and lung squamous cell carcinoma [6, 7].